Day One Biopharmaceuticals Inc (DAWN)
CapEx to Revenue
6.52%
Quarterly · Period ending:
DAWN CapEx to Revenue
Latest reported6.52%period ending
Latest reported6.52%period ending
DAWN Quarterly CapEx/Revenue (0.00% → 6.52%)
Latest values, visible window
High-resolution chart · PNG
DAWN capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 6.5155% | |
| 0% | |
| 10.3132% | |
| 12.4086% | |
| 4.8583% | |
| 59.432% | |
| 209.0576% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |